MNOV Company Profile and Key Details

Q: Who are the executives of MNOV?

Mr. John O'Neil CPAControllerMr. Jason J. Kruger CPAChief Financial Officer & Principal Financial OfficerDr. Yuichi Iwaki M.D., Ph.D.Co-Founder, Pres, Chief Executive Officer & Executive DirectorDr. Kazuko Matsuda M.D., M.P.H., MPH, Ph.D.Chief Medical Officer & DirectorDr. David H. Crean M.B.A., Ph.D.Chief Bus. Officer

NASDAQ : MNOV

MediciNova

$1.27

-0.005-0.39%

At Close 4:00 PM

70.05

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

MediciNova, Inc. (MNOV) stock declined over -0.39%, trading at $1.27 on NASDAQ, down from the previous close of $1.28. The stock opened at $1.27, fluctuating between $1.27 and $1.29 in the recent session.

Stock Snapshot

1.275

Prev. Close

62.51M

Market Cap

1.27

Day Low

-5.52

P/E Ratio

-0.23

EPS (TTM)

-0.15

Cash Flow per Share

1.27

Open

49.22M

Number of Shares

1.29

Day High

85.8%

Free Float in %

1.27

Book Value

19.64K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 10, 2026	1.27	1.29	1.27	1.27	19.65K
Jun 09, 2026	1.29	1.30	1.27	1.27	15.45K
Jun 08, 2026	1.35	1.35	1.30	1.30	35.36K
Jun 05, 2026	1.36	1.36	1.31	1.31	5.39K
Jun 04, 2026	1.31	1.34	1.31	1.32	8.77K
Jun 03, 2026	1.36	1.37	1.32	1.32	25.37K
Jun 01, 2026	1.36	1.37	1.35	1.37	42.94K
May 29, 2026	1.37	1.37	1.34	1.36	35.22K
May 28, 2026	1.32	1.37	1.32	1.37	33.88K
May 27, 2026	1.35	1.38	1.30	1.33	95.62K
May 26, 2026	1.40	1.40	1.36	1.37	33.01K
May 22, 2026	1.40	1.45	1.38	1.40	12.78K
May 21, 2026	1.39	1.39	1.36	1.37	19.23K
May 20, 2026	1.37	1.39	1.37	1.39	20.67K
May 19, 2026	1.40	1.40	1.38	1.38	21.86K
May 18, 2026	1.40	1.40	1.39	1.39	7.82K
May 15, 2026	1.39	1.39	1.37	1.38	17.84K
May 14, 2026	1.40	1.41	1.38	1.40	22.27K
May 13, 2026	1.38	1.38	1.37	1.37	12.04K
May 12, 2026	1.40	1.40	1.38	1.38	28.98K

Contact Details

La Jolla, CA 92037

United States

https://www.medicinova.com 858 373 1500

About Company

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Stock Peers

ARGX

-21.82-2.47%

argenx SE$862.18 REGN

-14.53-2.36%

Regeneron Pharmaceuticals, Inc.$601.65 UTHR

-9.04-1.63%

United Therapeutics Corporation$544.10 MDGL

-5.57-1.17%

Madrigal Pharmaceuticals, Inc.$471.32 VRTX

-10.06-2.26%

Vertex Pharmaceuticals Incorporated$435.71 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

2.66+0.86%

Krystal Biotech, Inc.$312.41 ALNY

-6.47-2.17%

Alnylam Pharmaceuticals, Inc.$291.22 LGND

4.96+2.04%

Ligand Pharmaceuticals Incorporated$248.24 AXSM

0.7+0.28%

Axsome Therapeutics, Inc.$246.34

Frequently Asked Questions

What is the current MediciNova, Inc. (MNOV) stock price?

MediciNova, Inc. (NASDAQ: MNOV) stock price is $1.27 in the last trading session. During the trading session, MNOV stock reached the peak price of $1.29 while $1.27 was the lowest point it dropped to. The percentage change in MNOV stock occurred in the recent session was -0.39% while the dollar amount for the price change in MNOV stock was - $0.01.

MNOV's industry and sector of operation?

The NASDAQ listed MNOV is part of Biotechnology industry that operates in the broader Healthcare sector. MediciNova, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MNOV?

Mr. John O'Neil CPA
Controller
Mr. Jason J. Kruger CPA
Chief Financial Officer & Principal Financial Officer
Dr. Yuichi Iwaki M.D., Ph.D.
Co-Founder, Pres, Chief Executive Officer & Executive Director
Dr. Kazuko Matsuda M.D., M.P.H., MPH, Ph.D.
Chief Medical Officer & Director
Dr. David H. Crean M.B.A., Ph.D.
Chief Bus. Officer

How MNOV did perform over past 52-week?

MNOV's closing price is 8.55% higher than its 52-week low of $1.17 where as its distance from 52-week high of $1.96 is -35.2%.

How many employees does MNOV have?

Number of MNOV employees currently stands at 13.

Link for MNOV official website?

Official Website of MNOV is: https://www.medicinova.com

How do I contact MNOV?

MNOV could be contacted at phone 858 373 1500 and can also be accessed through its website. MNOV operates from 4275 Executive Square, La Jolla, CA 92037, United States.

How many shares of MNOV are traded daily?

MNOV stock volume for the day was 19.64K shares. The average number of MNOV shares traded daily for last 3 months was 36.27K.

What is the market cap of MNOV currently?

The market value of MNOV currently stands at $62.51M with its latest stock price at $1.27 and 49.22M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	13
Beta	0.6
Sales or Revenue	$1.00M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	13
Beta	0.6
Sales or Revenue	$1.00M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

MNOV Company Profile and Key Details

MediciNova

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook